Virtu Financial LLC Horizon Therapeutics Public LTD CO Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$62.39 - $113.8 $2.96 Million - $5.4 Million	47,458 New	47,458 $5.4 Million
Q2 2022 Aug 09, 2022	BUY	$79.4 - $116.36 $1.58 Million - $2.32 Million	19,913 New	19,913 $1.59 Million
Q4 2021 Feb 17, 2022	SELL	$98.56 - $119.91 $444,899 - $541,273	-4,514 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $414,881 - $498,210	4,514 New	4,514 $494,000
Q4 2020 Feb 24, 2021	SELL	$67.0 - $84.39 $1.15 Million - $1.45 Million	-17,210 Closed	0 $0

Q3 2020 Dec 11, 2020	BUY	$55.23 - $79.93 $496,628 - $718,730	8,992 Added 109.42%	17,210 $1.34 Million
Q2 2020 Aug 07, 2020	BUY	$30.2 - $56.98 $248,183 - $468,261	8,218 New	8,218 $457,000
Q3 2019 Nov 20, 2019	SELL	$23.0 - $27.97 $243,593 - $296,230	-10,591 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$22.81 - $28.48 $241,580 - $301,631	10,591 New	10,591 $255,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.